Zethema Obtains Patent for 'Localized Injection Composition'
[Asia Economy Reporter Geum Bo-ryeong] Jetema announced on the 15th that it has acquired a patent related to 'local injection composition.'
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Jetema stated, "This patent is for a lyophilized dry powder formulation of a fat-dissolving injection agent with excellent storage stability," and explained, "It is characterized by DCA not precipitating in the injection water and dissolving well."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
